Exeens Capital Advisors Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -35.01%
(FY 2022)
- Profit 665.92%
(FY 2022)
- Ebitda 15.35%
(FY 2022)
- Net Worth 8.89%
(FY 2022)
- Total Assets -41.35%
(FY 2022)
About Exeens Capital Advisors
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyesh Ambalal, Ashwani Deedwania, and Sanchit Agarwal serve as directors at the Company.
- CIN/LLPIN
U65999MH2018PTC306275
- Company No.
306275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Exeens Capital Advisors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanchit Agarwal  | Director | 12-Mar-2018 | Current |
| Priyesh Ambalal | Director | 12-Mar-2018 | Current |
| Ashwani Deedwania | Director | 12-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Exeens Capital Advisors.
Exeens Capital Advisors Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.01% decrease. The company also saw a substantial improvement in profitability, with a 665.92% increase in profit. The company's net worth moved up by a moderate rise of 8.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exeens Capital Advisors?
Unlock access to Exeens Capital Advisors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Delicare Lifesciences Private LimitedActive 13 years 2 months
Ashwani Deedwania and Sanchit Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exeens Capital Advisors?
Unlock and access historical data on people associated with Exeens Capital Advisors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exeens Capital Advisors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exeens Capital Advisors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.